Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 23Breast Neoplasms 22Carcinoma, Non-Small-Cell Lung 17Rectal Neoplasms 13Prostatic Neoplasms 13Gliosarcoma 12Lung Neoplasms 10Head and Neck Neoplasms 10Esophageal Neoplasms 10Brain Neoplasms 10Neoplasms 9Uterine Cervical Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Adenocarcinoma Of Esophagus 8Sarcoma 7Neoplasm Metastasis 7Central Nervous System Neoplasms 7Pancreatic Neoplasms 6Melanoma 6Glioma 6Carcinoma, Squamous Cell 6Astrocytoma 6Urinary Bladder Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Burkitt Lymphoma 5Oropharyngeal Neoplasms 4Medulloblastoma 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Acute 4

Interventions

pembrolizumab 3Axitinib 2regorafenib 1avelumab 1amivantamab 1Tretinoin 1Specimen Handling 1Radiation 1Pemetrexed 1Nelfinavir 1Magnetic Resonance Spectroscopy 1Glutamate Carboxypeptidase II 1GSK-3326595 1Etoposide 1Endoscopic Mucosal Resection 1Doxorubicin 1Cisplatin 1Bortezomib 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Adenoid Cystic × Radiation × Clear all
NCT03087019 2022-10-14

Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Dana-Farber Cancer Institute

Phase 2 Completed
21 enrolled 11 charts

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡